home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Ago2 and Hematopoiesis

  July, 15 2007 6:15
your information resource in human molecular genetics
Argonaute 2 (Ago2) is unique among its family: It is the only one of the four mammalian Argonaute proteins that exhibits endonuclease “slicer” activity (facilitation of miRNA-guided cleavage of target mRNA).

However, as Drs. Donal O'Carroll and Alexander Tarakhovsky (The Rockefeller Institute) report in an upcoming issue of Genes and Development, Ago2's defining characteristic is surprisingly non-essential for its role in hematopoiesis and miRNA biogenesis.

Drs. O'Carroll, Tarakhovsky and colleagues generated transgenic mice harboring mutated versions of Ago2 in their bone marrow. The researchers found that Ago2 is, indeed, quite necessary for normal blood cell development. Its endonuclease activity, however, is not.

The scientists were able to restore erythropoiesis in Ago2-deficient mice by expressing a mutated version of Ago2 that lacks its endonuclease activity, thereby demonstrating that the role of Ago2 in the hematopoietic system is independent of its slicer activity. Rather, Dr. O'Carroll and colleagues found that Ago2 regulates miRNA biogenesis in blood cells.

“Our results suggest that the effector function of miRNA in somatic cells relies mostly on translational control of gene expression rather than on destruction of the mRNA targets. This finding may force rethinking of current strategies for the identification of miRNA targets in cells with individual miRNA overexpression or deficiency,” explains Dr. Tarakhovsky.

Source: Genes and Development Press Release

Dónal O’Carroll

Alexander Tarakhovsky

Message posted by: Robin Kimmel

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.